Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T20:07:57.156Z.
Calculation as of: 2026-10-06T20:07:57.156Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2100d4567e155cb65401b1d64ef1112e8effddeb5d941ccec26242c7dbad22d6
EARNINGS YIELD
N/A
Orchestra BioMed Holdings, Inc.
Market Cap
$349.70M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$353.88M
Earnings Yield
N/A
TTM Avg
2.17%
3Y Avg
3.20%
5Y Avg
4.68%
Market Cap
$355.36M
Earnings Yield
3.90%
TTM Avg
4.08%
3Y Avg
3.68%
5Y Avg
3.48%
Market Cap
$344.04M
Earnings Yield
N/A
TTM Avg
162.59%
3Y Avg
162.59%
5Y Avg
162.59%
Market Cap
$355.43M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$359.53M
Earnings Yield
N/A
TTM Avg
0.64%
3Y Avg
0.64%
5Y Avg
0.64%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | $349.70M | N/A | N/A | N/A | N/A |
| Turn Therapeutics Inc. (TTRX)vs › | $346.73M | N/A | N/A | N/A | N/A |
| Ocugen, Inc. (OCGN)vs › | $352.67M | N/A | 6.28% | 6.28% | 6.28% |
| Embecta Corp. (EMBC)vs › | $353.00M | 24.87% | 29.71% | 15.15% | 15.10% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.88M | N/A | 2.17% | 3.20% | 4.68% |
| Viemed Healthcare, Inc. (VMD)vs › | $355.36M | 3.90% | 4.08% | 3.68% | 3.48% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | N/A | 162.59% | 162.59% | 162.59% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | N/A | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | N/A | 0.64% | 0.64% | 0.64% |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
